As previously mentioned, a cohort of 234 patients studied by Boursi B. et al. (2023) indicated that there was no significant difference in overall survival between BRCA1/2-associated familial pancreatic cancer (FPC) with and without platinum exposure. Here, BRCA1 is linked to familial pancreatic carcinoma.